Enhancement of withstanding pressure of fibrin sealant by modified mixing ratio of fibrin sealant components for skull base reconstruction: technical note.
A method to enhance the withstanding pressure of fibrin sealant in gasket-seal closure to prevent cerebrospinal fluid (CSF) leakage after extended transsphenoidal surgery (ETSS) was investigated by adjusting the mixing ratio of the components. A plastic chamber (200 ml) was constructed with a lid made of hydroxyapatite with a hole 10 mm in diameter. The chamber could be pressurized via an opening in the side wall. The hole in the hydroxyapatite lid was covered with a Gore-Tex sheet, 15 mm in diameter. The margin of the sheet was free. Solutions A (fibrinogen 80 mg/ml) and B (thrombin 250 units/ml) of fibrin sealant were mixed in volume ratios of 1:1, 2:1, and 5:1, and applied to the Gore-Tex sheet, then water was introduced to cover the fibrin sealant. The pressure was measured at which air leakage occurred from the side of the Gore-Tex sheet. The pressure values for A/B ratios of 1:1, 2:1, and 5:1 were 117 ± 23.8 mmH(2)O (mean ± standard error) (n = 5), 234 ± 38.8 mmH(2)O (n = 5), and 345 ± 36.4 mmH(2)O (n = 5), respectively, in the acute phase (5 minutes after application of fibrin sealant). Pressures were increased after 24 hours, and that for 5:1 was the highest (373 ± 40.4 mmH(2)O, n = 5). The use of devices such as syringes specially designed to mix solutions A and B in the ratio of 5:1 can easily enhance the preventive effect of fibrin sealant against CSF leakage in ETSS.
Department of Neuromodulation and Neurosurgery, Office for University-Industry Collaboration, Osaka University, Suita, Osaka, Japan.
Youichi
Y
Saitoh
Satoru
S
Oshino
D000268:Adhesiveness; D065634:Cerebrospinal Fluid Leak; D002559:Cerebrospinal Fluid Rhinorrhea / Q000503:physiopathology / Q000517:prevention & control*; D017886:Durapatite; D015718:Fibrin Tissue Adhesive / Q000032:analysis / Q000138:chemical synthesis*; D006801:Humans; D007427:Intracranial Pressure / Q000502:physiology; D008953:Models, Anatomic; D044583:Neuroendoscopy / Q000379:methods*; D011138:Polytetrafluoroethylene; D011183:Postoperative Complications / Q000503:physiopathology / Q000517:prevention & control*; D019291:Skull Base / Q000601:surgery*; D013101:Sphenoid Sinus / Q000601:surgery*; D013718:Tensile Strength
D015718:Fibrin Tissue Adhesive; D011138:Polytetrafluoroethylene; D017886:Durapatite